UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[x] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~December 3031, 2010

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________to _______________

Commission file number 000-52885

PURE ~~PHARMACEUTICALS~~MINERALS ~~CORPORATION~~ INC. (Exact name of Registrant as Specified in Its Charter)

NEVADA	45-0476087
(State or Other Jurisdiction of Incorporation or	(IRS Employer Identification No.)
Organization)
P.O. BOX 55, 1594 STONE MILL PARK,
BELLONA, NY	14415
(Address of Principal Executive Offices)	(Zip Code)

(315) 849-2822 (Registrant’s Telephone Number, Including Area Code)

1200 McGill College Avenue, Suite 2050
Montreal, Quebec, Canada	H3B 4G7
(Address of Principal Executive Offices)	(Zip Code)

(514) 397-2683
(Registrant’s Telephone Number, Including Area Code)

________________
(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the exchange Act. (Check One)

Large Accelerated Filer [ ] Accelerated Filer [ ] Non-Accelerated Filer [X ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [x ] No [X ]

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.
Yes [ ] No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of March 10, 2011 the Registrant had outstanding 430,740 shares of Common Stock, par value, $0.001 per share.

12,600,000 shares of common stock, par value $0.001 per share

*Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer [ ]	Accelerated filer [ ]

Non-accelerated filer [ ]	Smaller reporting company [x]
(Do not check if a smaller reporting company)

PART 1
FINANCIAL INFORMATION

Item 1. Financial Statements.

PURE MINERALS, INC. ~~(Formerly Pure Pharmaceutical Corporation) (An Exploration Stage Company) FINANCIAL STATEMENTS June 30, 2010~~

~~PURE MINERALS, INC.~~ (~~Formerly Pure Pharmaceutical Corporation) (~~An Exploration Stage Company) ~~BALANCE SHEETS (Unaudited)~~

	June 30,		September 30,
	2010		2009
	- $ -		- $ -
ASSETS
Current
Cash	16,182		8,573
	16,182		8,573
LIABILITIES
Current
Accounts payable and accrued liabilities	24,295		30,771
Long-term loans (Note 2)	-		59,314
	24,295		90,085
STOCKHOLDERS’ DEFICIT
Common Stock (Note 3)
Authorized: 100,000,000 common shares with a par value of $0.001
Issued and Outstanding: 150,000 common shares (September 30, 2009 – 150,000)	150		150
Additional paid in capital	318,034		203,850
Accumulated comprehensive loss	2,439		2,439
Deficit accumulated during the exploration stage	(328,736	)	(287,951	)
	(8,113	)	(81,512	)
	16,182		8,573

FINANCIAL STATEMENTS

~~Subsequent~~DECEMBER ~~events~~31, ~~(Note~~2010 4)

PURE MINERALS, INC.

(An Exploration Stage Company)

BALANCE SHEETS

(Unaudited)

	December 31, 2010		September 30, 2010
	- $ -		- $ -

Assets
Current
Cash	9,389		9,412
	9,389		9,412

Liabilities
Current
Accounts payable and accrued liabilities	58,351		58,851


Stockholders’ Deficit
Common Stock
Authorized: 100,000,000 common shares with a par value of $0.001
Issued and Outstanding: 150,000 (September 30, 2010 – 150,000) common shares	150		150
Additional paid in capital	338,541		335,541
Deficit accumulated during the exploration stage	(387,653	)	(385,130	)
	(48,962	)	(49,439	)
	9,389		9,412

Subsequent events (Note 2)

– See Accompanying Notes –

PURE ~~MINMERALS~~MINERALS, INC. (~~Formerly Pure Pharmaceutical Corporation) (~~An Exploration Stage Company) STATEMENTS OF OPERATIONS (Unaudited)

									Cumulative
	Three months ended December 31,				Cumulative from September 24, 2004 (Inception) to December 31, 2010
					Nine		Nine		from
	2010		2009
	Three		Three		months		months		September 24,
	- $ -		- $ -		- $ -
	months		months		ended		ended		2004
Expenses
	ended June		ended June		June 30,		June 30,		(Inception) to
Financing fees	-		-		5,600
	30, 2010		30, 2009		2010		2009		June 30, 2010
General and administrative	2,523		11,516		380,866
	- $ -		- $ -		- $ -		- $ -		- $ -
Interest on long term loans	-		800		6,785
Revenue	-		-		-		8,310		20,398
Write-down of inventory	-		-		5,130
Cost of sales	-		-		-		-		9,670
	2,523		12,316		(398,381	)
	-		-		-		8,310		10,728
Net loss before other item	(2,523	)	(12,316	)	(398,381	)
Expenses
Other income	-		-		10,728
Financing fees	-		-		-		-		5,600
Net loss	(2,523	)	(12,316	)	(387,653	)
General and administrative	8,609		3,484		38,710		21,073		322,735
Loss per share – basic and diluted	(0.02	)	(0.08	)
Interest on long-term loans	-		-		2,075		-		5,999
Weighted average number of common shares outstanding – basic and diluted	150,000		150,000
Write-down of inventory	-		-		-		-		5,130
Net loss	(8,609	)	(3,484	)	(40,785	)	(12,763	)	(328,736	)
Loss per share – basic and diluted	(0.06	)	(0.02	)	(0.27	)	(0.09	)
Weighted average number of common shares outstanding – basic and diluted	150,000		150,000		150,000		150,000

– See Accompanying Notes –

PURE ~~MINMERALS~~MINERALS, INC. (~~Formerly Pure Pharmaceutical Corporation) (~~An Exploration Stage Company) STATEMENTS OF CASH FLOWS (Unaudited)

					Cumulative from
	Three months ended December 31,				Cumulative from September 24, 2004 (Inception) to December 31, 2010
	Nine		Nine		September 24,
	2010		2009
	months		months		2004 (Inception)
	ended		ended		to March 31,
	June 30, 2010		June 30, 2009		2010
	- $ -		- $ -		- $ -
Cash Flows From Operating Activities
Net loss	(402,~~785~~523	)	(12,~~763~~316	)	(~~328~~387,~~736~~653	)
Non-cash items:
Donated capital	7,200		11,084		55,200
Accrued interest on long term loan	-		800		3,924
Accrued interest on long term loan	2,075		-		5,999
Donated capital	-		2,400		57,600
Write-down of inventory	-		-		5,130
Write down of inventory	-		-		5,130
Change in non-cash working capital items
Change in non-cash working capital items:
Inventory	-		-		(5,130	)
Accounts payable and accrued liabilities	(~~6,476~~500	)	(276,~~480~~264	)	2458,~~295~~351
Net cash used in operations	(37,986	)	(29,159	)	(243,242	)
Net cash used in operating activities	(3,023	)	(15,380	)	(267,778	)
Cash Flows From Financing Activities
Proceeds from (repayment of) long-term loans	(61,389	)	14,224		(5,999	)
Proceeds (Repayments) from long-term loans	-		(16,683	)	(3,924	)
Donated capital	~~106~~3,~~984~~000		-30,000		~~126~~145,~~984~~091
Capital stock issued for cash	-		-		136,000
Net cash provided by financing activities	453,~~595~~000		1413,~~224~~317		~~256~~277,~~985~~167
Effect of exchange rate changes	-		3,335		2,439
Increase (Decrease) In Cash	(23	)	(2,063	)	9,389
Increase (Decrease) In Cash	7,609		(11,600	)	16,182
Cash, beginning	9,412		8,573		-
Cash, beginning	8,573		12,459		-
Cash, ending	9,389		6,510		9,389
Cash, ending	16,182		859		16,182
Supplementary Cash Flow Information:
Cash paid for:
Interest	~~5,999~~-		-		56,~~999~~785
Income taxes	-		-		-

-– See Accompanying Notes -–

PURE ~~MINMERALS~~MINERALS, INC. (~~Formerly Pure Pharmaceutical Corporation) (~~An Exploration Stage Company) NOTES TO ~~THE~~ FINANCIAL STATEMENTS ~~June~~DECEMBER 3031, 2010 (Unaudited)

1. BASIS OF PRESENTATION Unaudited Interim Financial Statements The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. They may not include all information and footnotes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the year ended September 30, 2009, included in the Company’s Form 10-K filed with the Securities and Exchange Commission. The unaudited interim financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the nine months ended June 30, 2010 are not necessarily indicative of the results that may be expected for the year ending September 30, 2010. 2. LONG-TERM LOANS During the nine months ended June 30, 2010, the Company fully repaid the long term loans in the amount of $61,389 including accrued interest of $5,999. 3. COMMON STOCK During the nine months ended June 30, 2010, the Company received $30,000 as the second installment of a $50,000 non-refundable deposit under the terms of a Letter of Intent (“LOI”) entered into with 7167415 Canada Inc. (“7167415”) on July 21, 2009. The LOI expired on July 23, 2009 and a definitive agreement was not completed. Accordingly, the non-refundable deposit was recorded as additional paid in capital. During the nine months ended June 30, 2010, the Company received $76,984 from 7167415 to repay long-term loan and to fund operating expenses. These funds were donated to the Company and it has no obligation to repay these funds. Accordingly, the $76,984 was recorded as additional paid in capital. On June 23, 2010, the Company completed a reverse tock split of eighty four for one. There has been no change to the authorized share capital. The stock split has been reflected in these financials statements retroactively for all periods presented.

1.	BASIS OF PRESENTATION

	Unaudited Interim Financial Statements

	The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. They may not include all information and footnotes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the year ended September 30, 2010, included in the Company’s Form 10-K filed with the Securities and Exchange Commission. The unaudited interim financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the three months ended December 31, 2010 are not necessarily indicative of the results that may be expected for the year ending September 30, 2011.

2.	SUBSEQUENT EVENTS

	a)	On January 26, 2011, the Company closed the share exchange agreement (the “Share Exchange Agreement”) with the shareholders of 7167415 Canada Inc. (“7167415”), a privately owned, unrelated mineral exploration company that owns mining claims in the Province of Quebec, Canada. Pursuant to the Share Exchange Agreement, all of the outstanding shares of 7167415 was acquired by a newly incorporated subsidiary of the Company, (the “Share Exchange”). In connection with the Share Exchange, the Company acquired 100% of the outstanding capital stock of 7167415 and the stockholders of 7167415 received preferred shares of a newly incorporated subsidiary exchangeable into 7,350,000 shares of the Company’s common stock. As a result of the Share Exchange, the stockholders of 7167415 controlled approximately 94% of the Company’s outstanding common stock on closing date.

	b)	Subsequent to December 31, 2010. The Company issued 280,740 common shares at $1.35 per share. The subscriptions were held in trust by 7167415 for the investors. The closing of the subscription was subject to the closing of the Share Exchange Agreement.

4.	SUBSEQUENT EVENTS
	On June 14, 2010, the Company entered into a share exchange agreement (the “Share Exchange Agreement”) with the shareholders of 7167415. Pursuant to the Share Exchange Agreement, all of the outstanding shares of 7167415 will acquired by a subsidiary of the Company, with 7167415 continuing as a wholly-owned subsidiary of the Company (the “Share Exchange ”). In connection with the Share Exchange, the Company will acquire 100% of the outstanding capital stock of 7167415 and the stockholders of 7167415 will receive preferred shares of a subsidiary of the Company exchangeable into 7,500,000 shares of the Company’s common stock. As a result of the Share Exchange, the stockholders of 7167415 will control approximately 98% of the Company’s outstanding commons stock. As at August 23, 2010, the Share Exchange Agreement has not closed.
	The Company amended its Article of Incorporation to effect a name change from Pure Pharmaceutical Corporation to Pure Minerals, Inc..

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

~~Item~~Forward 2.Looking ~~Management's~~Statements ~~Discussion and Analysis of Financial Condition and Results of Operations.~~

~~Forward~~In ~~Looking~~addition ~~Statements~~to historical information, the following discussion and other parts of this document may contain forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," or "continue," the negative of such terms or other comparable terminology. These statements are only predictions. The events described in forward looking statements we make in this Form 10-Q may not occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties risks and other influences, many of which are beyond our control that may influence the accuracy of the statements and the projections upon which the statements are based. Moreover, neither we nor any other person assume responsibility for the accuracy and completeness of the forward-looking statements. Except as may be required by law, we undertake no obligation to publicly update any of the forward-looking statements after the date of this report to conform such statements to actual results or to changes in our expectations.

InActual ~~addition~~results tocould ~~historical~~differ ~~information,~~materially ~~the~~from ~~following~~those ~~discussion~~anticipated ~~and~~by ~~other~~such ~~parts of this document may contain~~ forward-looking statements. ~~These statements~~The ~~relate~~following todiscussion ~~future~~should ~~events~~be orread ~~our future financial performance. In some~~in ~~cases,~~conjunction ~~you~~with ~~can~~the ~~identify~~financial ~~forward-looking~~ statements byas ~~terminology~~well ~~such~~ as ~~"may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," or "continue," the negative of such terms or~~ other ~~comparable~~ ~~terminology.~~financial ~~These statements are only predictions. The events~~information ~~described~~appearing inelsewhere ~~forward looking statements we make~~ in this ~~Form 10-Q may not occur~~document. ~~Although~~ weReaders ~~believe that the expectations reflected in the forward-looking statements~~ are ~~reasonable,~~also weurged ~~cannot guarantee future results, levels of activity, performance or achievements. We caution you that these statements are not guarantees of future performance or events and are subject~~ to acarefully ~~number of~~review ~~uncertainties risks~~ and ~~other~~consider ~~influences, many of which are beyond our control that may influence~~ the ~~accuracy~~various ofdisclosures ~~the~~made ~~statements~~by ~~and~~us ~~the projections upon~~ which ~~the~~ ~~statements~~attempt ~~are~~to ~~based. Moreover, neither we nor any other person assume~~advise ~~responsibility~~interested ~~for~~parties ~~the accuracy and completeness~~ of the ~~forward-looking statements.~~factors ~~Except~~which asaffect ~~may be required by law, we undertake no obligation to publicly update any of the forward-looking statements after the date of this report to conform such statements to actual results or to changes in~~ our ~~expectations~~ business.

~~Actual~~Our ~~results~~Business could differ materially from those anticipated by such forward-looking statements. The following discussion should be read in conjunction with the financial statements as well as other financial information appearing elsewhere in this document. Readers are also urged to carefully review and consider the various disclosures made by us which attempt to advise interested parties of the factors which affect our business.

The Company was formed in order to seek business opportunities in the area of expertise of the Company's former principal officer, Mr. Roger Gordon, being biological and/or medical products for animal use. The Company principally operated in the field of generic animal health and nutrition products, specifically medicated feed additives (MFAs). MFAs are used preventively and therapeutically in animal feed to prevent disease and foster growth in livestock. In North America, 90% of all feed to animals contain MFAs, but has been on the decrease in the last five years. Our ~~Business~~intended customers operate in the poultry, swine and cattle markets. The Company has historically focused its efforts on generic MFAs, as they have come off patent, therefore making them more economical to register with requisite regulators in the United States and Canada, with a view to bringing the products to market.

The Company ~~was~~ceased ~~formed~~to inmarket ~~order~~an tounder ~~seek~~licensed ~~business opportunities~~related-party inowned ~~the~~MFA, ~~area~~Oxytetracycline, ofand ~~expertise~~is ofcontinuing ~~the~~its ~~Company's~~discussions ~~principal~~with ~~stockholder,~~7167415 Canada MrInc. ~~Roger Gordon,~~(“7167415”) ~~being~~in ~~biological~~connection ~~and/or~~with ~~medical~~a ~~products~~share ~~for~~exchange ~~animal~~pursuant ~~use.~~to ~~The Company~~which ~~principally~~control ~~operated~~of in the ~~field~~Company ofmay ~~generic~~be ~~animal~~sold ~~health~~to ~~and~~the ~~nutrition products,~~shareholders ~~specifically~~of ~~medicated feed additives (MFAs)~~7167415. ~~MFAs~~As ~~are used~~market ~~preventively~~dynamics ~~and~~have ~~therapeutically~~undergone insignificant systemic ~~animal~~changes ~~feed~~over tothe ~~prevent~~past ~~disease~~four ~~and~~years ~~foster growth~~with inthe ~~livestock.~~emergence Inof ~~North~~avian ~~America,~~flu ~~90%~~and ofthe ~~all~~attendant ~~feed~~fall toin ~~animals~~poultry ~~contain~~consumption ~~MFAs~~worldwide, ~~but~~ ~~has~~management ~~been~~realized on the ~~decrease~~identification inprocess ~~the~~for ~~last~~new ~~five~~MFAs ~~years.~~cannot ~~Our~~be ~~intended~~done ~~customers operate~~with in the ~~poultry,~~limited ~~swine~~resources ~~and~~of ~~cattle~~the ~~markets. The~~ Company ~~has historically~~. ~~focused~~Furthermore, ~~its~~with ~~efforts~~the onprices ~~generic~~of ~~MFAs~~feed, asparticularly ~~they~~maize, ~~have~~at ~~come~~record ~~off~~high ~~patent~~prices, ~~therefore making~~out ~~them~~intended ~~more~~customers ~~economical~~have tobeen ~~register~~hesitant ~~with requisite regulators in the United States and Canada, with a view~~ to ~~bringing~~add ~~the products~~ to ~~market~~their expenses.

The Company's ~~ceased~~activities to ~~market~~date anhave ~~under~~been ~~licensed~~primarily ~~related-party owned~~organizational ~~MFA,~~in ~~Oxytetracycline,~~nature and isas ~~continuing its discussions with 7167415 Canada Inc. (“7167415”) in connection with~~ a ~~share~~result ~~exchange pursuant to which control of~~ the Company ~~may~~must be ~~sold~~considered to ~~the~~be ~~shareholders~~in ofits ~~7167415~~developmental stage. AsThe ~~market dynamics~~Company ~~have~~relies ~~undergone~~solely ~~significant~~on ~~systemic changes over~~ the ~~past~~efforts ~~four~~of ~~years with~~its ~~the~~management ~~emergence~~and ofdirector ~~avian flu~~ and ~~the~~has ~~attendant~~no employees, ~~fall~~owns infew ~~poultry~~business ~~consumption worldwide~~assets, ~~management~~technology ~~realized~~or ~~the~~real ~~identification~~estate ~~process~~and ~~for~~since ~~new~~inception ~~MFAs~~has ~~cannot~~been ~~be done~~primarily ~~with~~involved ~~the~~in ~~limited~~developing ~~resources~~and ofrefining ~~the~~its ~~Company.~~business ~~Furthermore~~plan, ~~with~~preliminarily ~~the~~identifying ~~prices~~generic ofMFAs ~~feed,~~for ~~particularly maize~~registration, atraising ~~record~~initial ~~high prices~~capital, ~~out~~and looking ~~intended~~for ~~customers~~other ~~have~~potential ~~been~~shareholder ~~hesitant~~maximizing tocorporate ~~add to their expenses~~actions.

~~The~~ Management ~~Company's~~previously ~~activities~~determined to ~~date~~refocus, ~~have~~assess ~~been primarily organizational in nature~~ and asidentify aalternative ~~result~~business ~~the~~strategies ~~Company~~due ~~must be considered~~ to beprolonged ~~in its~~high ~~developmental~~prices ~~stage. The Company relies solely on the efforts~~ of ~~its management~~maize and ~~director~~other ~~and~~inputs ~~has no employees, owns few business assets, technology or real estate~~ and ~~since~~other ~~inception~~general ~~has~~systemic ~~been~~economic ~~primarily~~conditions ~~involved~~affecting ~~in developing~~the ~~and refining its~~ business ~~plan,~~of ~~preliminarily~~the ~~identifying generic MFAs for registration, raising initial capital, and looking for other potential shareholder maximizing corporate actions~~Company.

~~Management previously determined to refocus, assess and~~ ~~identify~~Recent ~~alternative~~Developments ~~business strategies due to prolonged high prices of maize and other inputs and other general systemic economic conditions affecting the business of the Company.~~

~~Recent~~ The ~~Developments~~Company has booked no sales for this period and had received $3,000 donated capital from an outside third party during the three month period ended December 31, 2010. As a result of the prolonged high prices of inputs and other general conditions affecting the business of the Company, management determined, earlier in its fiscal year, to refocus, assess and identify alternative business strategies. In July 2008, the Company was quoted on the OTC Bulletin Board under the symbol “PPMA”.

~~The Company has booked no sales for this period and had~~ ~~received~~ ~~$61,389~~On ~~donated capital from an outside third party during the nine month period ended~~ June 3013, 2010~~. As a result of the prolonged high prices of inputs and other general conditions affecting the business of the Company~~, ~~management~~ ~~determined,~~Pure ~~earlier~~Pharmaceuticals ~~in its fiscal year, to refocus, assess and identify alternative business strategies~~Corp. ~~In July 2008~~, ~~the~~a ~~Company~~Nevada ~~was~~corporation ~~quoted on~~ (the ~~OTC Bulletin Board under the symbol~~ “~~PPMA~~Company”~~. On June 14~~), ~~2010, the Company~~ entered into a share exchange agreement (the “Share Exchange Agreement”) with the shareholders of 7167415 Canada Inc (“7167415”). Pursuant to the Share Exchange Agreement, assubject ofto the ~~date~~satisfaction of a number of conditions, all of the outstanding shares of 7167415 ~~will~~ were to be acquired by the Company, with 71674105 continuing as a wholly-owned subsidiary of the Company (the “Share Exchange ”). In connection with the Share Exchange, the Company ~~will~~agreed ~~acquire~~to ~~100~~acquire100% of the outstanding capital stock of ~~7167415~~ ~~and the stockholders of~~ 7167415 ~~will~~in ~~receive~~exchange for preferred shares of a subsidiary of the Company exchangeable ~~into~~for 7,~~500~~350,000 shares of the Company’s common stock. Among the conditions to the closing was 7167415 acquiring certain mining claims in the Belleterre region of Quebec.All of the conditions to closing of the Share Exchange Agreement were be satisfied on January 26, 2011 and the parties proceeded to close the Share Exchange. In connection with the Share Exchange the Company agreed to change its name to Pure Minerals, Inc.

As a result of the Share Exchange, the stockholders of 7167415 ~~will~~ ~~control~~controlled approximately 98% of the Company’s outstanding common stock, holding 7,350,000 of the 7,~~500~~780,~~000~~740 outstanding shares (after giving effect to a 84 for one reverse stock split, the issuance of 280,740 shares in a private placement which closed concurrent with the share exchange and assuming the conversion of the exchangeable preferred shares), and 7167415 is considered the accounting acquirer in the Share Exchange. The Company was a “shell company” (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) immediately prior to the Share Exchange. As a result of the Share Exchange, the Company’s operations are now focused in exploration for minerals on the Company’s properties in Quebec, Canada. Consequently, the Company believes that the Share Exchange has caused the Company to cease being a shell company as it no longer has nominal operations.

InResults ~~addition, pursuant to the Share Exchange Agreement, Roger Gordon will submit his resignation as an officer and director~~ of the Company and Charlie Lee as Secretary and Principal Financial Officer of the Company, and Nicolas Matossian, Charles Buisson and Andrew Gertler will be appointed to serve as members of the board of directors of the Company, all of which will be effective following the expiration of the ten day period following the mailing of the information statement required by Rule 14f-1 under the Exchange Act. Upon the consummation of the Share Exchange, Roger Gordon will resign as President and Chief Executive Officer, Nicolas Matossian will be appointed to serve as Chief Executive Officer, President and Chief Financial Officer of the Company, and Joseph P. Galda will be elected Corporate Secretary.Operations

~~In addition, at a Special Meeting of Shareholders held on June~~ ~~23,~~Results ~~2010, the stockholders~~ of ~~the~~Operations ~~Company~~for ~~approved an amendment to~~ the ~~Company’s Articles~~Period ofended ~~Incorporation~~December ~~to effect a reverse stock split of 84 to 1~~31, ~~without~~2010 ~~changing the authorized capital thereof and an amendment to the Company’s Articles of Incorporation to change the name of the Company to “Pure Minerals, Inc.”~~

~~Although~~ The ~~the~~Company ~~date~~did ~~specified~~not earn any revenues in the ~~Share~~three ~~Exchange~~months ~~Agreement~~ended ~~for~~ December 31, 2010. We incurred operating expenses in the ~~Closing~~amount of $2,523 for the ~~Share~~three ~~Exchange~~months ~~has~~ended ~~passed~~December 31, 2010. Our net loss for the ~~parties~~three ~~are~~months ~~working~~ended ~~together~~December 31, 2010 was to$2,523 ~~complete~~as ~~the~~compared ~~Closing.~~to ~~The~~net ~~aforementioned~~loss ~~amendment~~of to$12,316 for the ~~Certificate~~three ~~of Incorporation~~months ~~will~~ended beDecember ~~filed~~31, ~~immediately~~2009. ~~prior~~As toat ~~the~~December ~~Closing~~31, ~~which~~2010 ~~should~~we ~~be completed~~had ~~within~~cash ~~the~~of ~~week~~$9,389. ~~following~~The Company’s losses stem from the ~~filing~~payment of ~~this~~professional ~~Quarterly Report~~fees.

~~Results~~ The Company ceased its sales and marketing of ~~Operations~~the Company’s Oxytetracyline as well as the process of the Company pursuing opportunities in the generic MFAs areas. As stated in the prior quarter, the Company will not be importing further Oxytetracyline from the People’s Republic of China which is idleling production until the overall economic situation improves; and our factory suppliers have remained dormant and have not provided an ETA as to when production would resume. Due to acute fluctuations in the price of key ingredients; corn and soybeans; the ability for producers to manage price pressure is severely challenged. Corn prices see-sawed and surged 3 to-5 fold in the last 24 months to $750 USD per bushel mid 2008. Since its high, the price has continued its volatility and as an example from June 1st to December 31th 2009 prices swung 22% in 30 days from $425 USD per bushel to $350 USD per bushel. Farmers and buyers are taking a wait and see approach and farmers in particular are not selling their crops and trying to time the market. Management and analysts believe the competition for corn, once viewed as a commodity and now viewed as a matter of national security for countries, is here to stay. Though prices have dropped in the first six months of 2009, the price is still double that of three years ago in January 2006, and have trended upwards in the last half of 2009 The use of corn for the production of ethanol and the agricultural polices of leading petroleum usage countries continue to exert price and demand pressures on the market1. Also confounding the problem is worldwide health concerns and reaction to animal borne disease transmission to humans.

~~Results~~ Due to the prolonged uncertainty and relative high historic prices of ~~Operations~~inputs, this upward cycle has lasted for 3 years, and general economic conditions which are affecting the ~~Period~~business ~~ended~~of ~~June~~the ~~30,~~company; ~~2010~~management has determined to refocus, assess, and identify alternative business strategies.

~~The~~Our ~~Company~~cash ~~did~~reserves of $9,389 as at December 31, 2010 are not ~~earn~~sufficient ~~any~~to ~~revenues~~meet inour funding needs beyond the ~~previous~~short-term. ~~three~~To this ~~months~~effect, ~~ended~~the ~~June~~Company ~~30,~~will ~~2010.~~need Weto ~~incurred~~seek ~~operating~~additional ~~expenses~~funding in the ~~amount~~near offuture. We ~~$8,609~~are ~~and~~exploring ~~$40,785~~a ~~for~~number of alternative funding options although as of the ~~three~~date ~~and~~of this ~~nine~~Report ~~months~~we ~~ended~~have ~~June~~not ~~30,~~received ~~2010~~any firm commitments. ~~Our~~Short-term ~~net~~cash needs are ~~loss~~being ~~for~~met by short-term loans from the ~~three~~Company’s ~~and~~principal ~~nine~~stockholders. ~~months~~We currently ~~ended~~do ~~June~~not ~~30,~~have ~~2010~~a ~~was~~specific ~~$8,609~~plan ~~and~~for ~~$40~~obtaining such funding,~~785~~ ashowever, we ~~compared~~anticipate tothat ~~net~~any ~~loss~~additional offunding ~~$3,484~~will ~~and~~be ~~$12,763~~in ~~for~~the form of equity financing from the ~~three~~sale ~~and~~of ~~nine~~our ~~months~~common ~~ended~~stock. We currently do not have any arrangements in ~~June~~place ~~30,~~for ~~2009~~any future equity financing. AsWe atmay ~~June~~also ~~30,~~seek ~~2010~~to weobtain ~~had~~short-term loans ~~cash~~from ofour ~~$16~~directors,~~182.~~ ~~The~~although ~~Company’s~~no ~~losses~~such arrangements have as yet been made. ~~stem~~There can be no assurance that we will able to raise sufficient funding from the sale ~~payment~~ of ~~professional~~our ~~fees~~common stock or through director loans to meet our funding needs after the next two months.

~~The~~There ~~Company~~are ~~ceased~~two ~~its~~simultaneous ~~sales~~phases ~~and~~to ~~marketing of the Company~~7167415’s ~~Oxytetracyline~~ ~~as well as the process of the Company pursuing opportunities in~~proposed ~~the~~exploration ~~generic~~program; ~~MFAs~~firstly ~~areas.~~7167415 ~~As stated in the prior quarter, the Company~~ will ~~not~~delineate ~~be importing further Oxytetracyline from~~ the ~~People’s~~extent ~~Republic of China which is idleling production until the overall economic situation improves;~~ and ~~our factory~~quality ~~suppliers have remained dormant and have not provided an ETA as to when~~of ~~production would resume. Due to acute fluctuations in~~ the ~~price~~granite ofdyke ~~key ingredients;~~(diabase) ~~corn~~with ~~and~~a ~~soybeans;~~view ~~the ability for producers~~ to ~~manage~~determine ~~price pressure~~its iseconomic ~~severely challenged. Corn prices see-sawed~~ and ~~surged 3 to-5 fold in~~commercial ~~the last 24 months to $750 USD per bushel mid 2008~~feasibility. ~~Since~~7167415 ~~its high, the price~~ has ~~continued~~engaged ~~its volatility and as~~ an ~~example~~independent ~~from~~geologist ~~June 1st~~ to ~~December~~ ~~31th~~prepare ~~2009~~a ~~prices swung 22% in 30 days from $425 USD per~~reserve ~~bushel~~report tofor ~~$350~~the ~~USD per bushel~~diabase. ~~Farmers~~There ~~and buyers~~ are ~~taking~~several aoperating ~~wait~~ and ~~see approach~~marketing ~~and~~avenues ~~farmers~~ open in ~~particular are not selling their crops and trying to time~~ the ~~market.~~conventional ~~Management~~quarrying and ~~analysts~~cutting ~~believe the competition for corn, once viewed as a commodity and now viewed as a matter~~ of ~~national security for countries, is here to stay~~blocks. ~~Though~~To ~~prices have dropped in the first six months of 2009, the price is still double~~ that ofeffect ~~three~~7167415 ~~years ago in January 2006, and~~will ~~have~~seek ~~trended~~to ~~upwards~~ally initself ~~the~~with ~~last~~one ~~half~~or ofmore ~~2009~~major ~~The~~operator ~~use~~/ ofmarketer ~~corn~~by ~~for~~way ~~the production~~ of ~~ethanol~~a ~~and the agricultural polices of leading petroleum usage countries~~joint ~~continue~~venture toor ~~exert~~other ~~price~~supply/operating ~~and demand pressures on the market1~~arrangements. ~~Also confounding the problem is worldwide health concerns and reaction to animal borne disease transmission to humans.~~

~~Due~~In toits other phase, 7167415 will retain the ~~prolonged~~services ~~uncertainty~~of independent ~~and~~geologists ~~relative~~to ~~high~~prepare ~~historic~~a proposal for exploration work and costing ~~prices~~out of ~~inputs,~~the ~~this~~exploration ~~upward~~work ~~cycle~~program. ~~has~~The ~~lasted~~exploration program will extend to the further work required for 3a ~~years~~better assessment of the Kimberlites, the gold, platinum and ~~general~~uranium ~~economic conditions~~showings. ~~which~~This ~~are~~work ~~affecting~~will define the ~~business~~priorities ofand financing ~~the~~needs ~~company;~~for ~~management~~a ~~has determined~~full exploration program which the Company intends to ~~refocus,~~fund through ~~assess,~~a ~~and~~subsequent ~~identify~~flow ~~alternative~~through ~~business~~share ~~strategies~~issue.

Our cash reserves of $16,182 as at June 30, 2010 are not sufficient to meet our funding needs beyond the short-term. To this effect, the Company will need to seek additional funding in the near future. In connection with the Share Exchange with 7167415 we anticipate access to additional funding to support its exploration plan. We anticipate that any additional funding will be in the form of equity and debt financing from the sale of our common stock and/or loans (interest or convertible). There can be no assurance that we will be able to raise sufficient funding from the sale of our common stock or through director loans to meet our funding needs after the next nine months.

Exploration Budget

Granite Reserve Development
Preparation of Reserve Report	$	35,000
Drilling	$	50,000
Mineral Sampling/Cutting	$	50,000
Total Granite Reserve Development	$	135,000

The Independent Auditor's Report to our audited financial statements for the period ended September 30, 2009 indicated that there are a number of factors that raise substantial doubt about our ability to continue as a going concern. Such factors identified in the report include that we need to generate profitable operations and are in need of obtaining adequate financing. For these and other related reasons our auditors believe that there is substantial doubt that we will be able to continue as a going concern.

Other Mineral Exploration and Development
Acton Option Property
Gravimetric study (continuation)	$ 75,000
Drilling three anomalies (12 test holes)	$ 200,000
Data compliation and reporting	$ 25,000

Belleterre Prospect
Trenching, surface mag and Geiger counter study	$ 150,000
Drilling	$ 350,000
Data compliation and reporting	$ 75,000

Eau Jaune Prospect
Data review and exploration program development	$ 35,000
Diamond drilling (3000m)	$ 300,000
Total Other Mineral Exploration	$1,210,000

~~Off-Balance~~The ~~Sheet~~Independent ~~Arrangements~~Auditor's Report to our audited financial statements for the period ended September 30, 2010 indicates that there are a number of factors that raise substantial doubt about our ability to continue as a going concern. Such factors identified in the report include that we need to generate profitable operations and are in need of obtaining adequate financing. For these and other related reasons our auditors believe that there is substantial doubt that we will be able to continue as a going concern.

~~The Company does not have any off~~Off-~~balance~~Balance ~~sheet~~Sheet ~~arrangements that~~Arrangements have or are reasonably likely to have a current or future effect on the small business issuer's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

~~Item~~The 3.Company ~~Quantitative~~does ~~and~~not ~~Qualitative~~have ~~Disclosures~~any ~~About~~off-balance ~~Market~~sheet ~~Risk~~arrangements that have or are reasonably likely to have a current or future effect on the small business issuer's financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

~~Not~~Item ~~applicable~~3. Quantitative and Qualitative Disclosures About Market Risk.

~~Item~~Not 4applicable. ~~Controls and Procedures.~~

~~Evaluation~~Item of4. ~~Disclosure~~ Controls and Procedures. The Company's Management under the supervision and with the participation of the Principal Executive Officer and the Principal Financial Officer are responsible for establishing and maintaining "disclosure controls and procedures" (as defined in the Exchange Act) for the Company. Based on their evaluation of the Company's disclosure controls and procedures as of June 30, 2010 the Company's Management has concluded that the Company's disclosure controls and procedures were effective to ensure that the information required to be disclosed by the Company under the Exchange Act was recorded, processed, summarized and reported within the time periods specified in the Exchange Act and accumulated and communicated to the Company's Management, including the Principal Executive Officer and the Principal Financial Officer, to allow timely decisions regarding required disclosure.

~~Changes~~Evaluation inof ~~Internal~~Disclosure ~~Control~~Controls ~~over~~and ~~Financial Reporting~~Procedures. The ~~During~~Company's Management under the ~~fiscal~~supervision ~~quarter~~and ~~ending~~with ~~June~~the ~~30,~~participation ~~2010,~~of ~~there~~the Principal ~~were~~Executive noOfficer ~~changes~~and the Principal Financial Officer are responsible for establishing and maintaining "disclosure controls and procedures" (as defined in the Exchange Act) for the Company. Based on their evaluation of the Company's ~~internal~~disclosure ~~control~~controls ~~over~~and ~~financial~~procedures ~~reporting~~as ~~during~~of December 31, 2010 the ~~period~~Company's ~~covered~~Management ~~by this~~has ~~report~~concluded that ~~have~~the ~~materially~~Company's disclosure ~~affected~~controls and procedures were not effective, ordue ~~are~~to ~~reasonably~~the ~~likely~~lack of segregation of duties, to ensure that the information required to be disclosed ~~materially~~by ~~affect~~the Company under the Exchange Act was recorded, processed, summarized and reported within the time periods specified in the Exchange Act and accumulated and communicated to the Company's ~~internal~~Management, ~~control~~including ~~over~~the ~~financial~~Principal ~~reporting.~~Executive Officer and the Principal Financial Officer, to allow timely decisions regarding required disclosure.

~~Limitations~~Changes onin ~~the~~Internal ~~Effectiveness~~Control ofover ~~Controls.~~Financial ~~A control~~Reporting. ~~system,~~During nothe ~~matter~~fiscal ~~how~~quarter ~~well~~ending ~~conceived~~December ~~and operated~~31, ~~can provide only reasonable~~2010, ~~not~~ ~~absolute,~~there ~~assurance~~were ~~that~~no changes in the ~~objectives~~Company's ofinternal ~~the~~ control ~~system~~over ~~are~~financial ~~met.~~reporting ~~Because~~during of the ~~inherent limitations in all~~period ~~control~~covered ~~systems,~~by nothis ~~evaluation~~report ~~of controls can provide absolute assurance~~ that ~~all~~ ~~control~~have ~~issues,~~materially ~~if any~~affected, ~~within~~or ~~a company have been detected. The Company's disclosure controls and procedures~~ are ~~designed~~reasonably likely to ~~provide~~materially ~~reasonable assurance of achieving their objectives~~affect, ~~and~~ the ~~Principal~~Company's ~~Executive~~internal ~~Officer~~control ~~and~~over ~~the Principal~~financial ~~Financial Officer have concluded that these controls and procedures are effective at the "reasonable assurance" level~~reporting.

~~Item~~Limitations ~~4T.~~on the Effectiveness of Controls. A control system, no matter how well conceived and ~~Procedures~~operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. The Company's disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and the Principal Executive Officer and the Principal Financial Officer have concluded that these controls and procedures are effective at the "reasonable assurance" level.

~~The~~PART ~~Company's~~II ~~management~~– isOTHER ~~responsible~~INFORMATION for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

~~Our~~Item ~~internal~~1. ~~control~~Legal ~~over financial reporting includes those policies and procedures that:~~ Proceedings.

~~Pertain~~We toare ~~the~~not ~~maintenance~~currently ofa ~~records~~party ~~that,~~to inany ~~reasonable~~legal ~~detail, accurately~~proceedings. ~~and fairly reflect the transactions and dispositions of the assets of the Company;~~

~~Provide~~Item ~~reasonable~~1A. ~~assurance~~Risk that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of management and the director; and Factors.

~~Provide~~Not ~~reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements~~applicable.

AsItem ~~required~~2. byUnregistered ~~Rule~~Sales ~~13a-15~~of ~~and~~Equity ~~15d-15 under the~~ Securities and ~~Exchange~~Use ~~Act~~ of ~~1934, Management assessed the effectiveness of the Company’s internal control over financial reporting as of June 30, 2010~~Proceeds. Based on this assessment, the Company's management has concluded that the Company maintained effective internal control over financial reporting as of June 30, 2010, the end of the period covered by this quarterly report.

~~This quarterly report does not include an attestation report of the company's registered public accounting firm regarding internal control over financial reporting~~None. Management's report was not subject to attestation by the company's registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission ("SEC") that permit the Company to provide only management's report in this quarterly report.

~~Changes~~Item ~~in Internal Control over Financial Reporting~~3. ~~Management~~ ~~has~~Defaults ~~evaluated~~Upon ~~whether~~Senior any changes in our internal control over financial reporting that occurred during our last fiscal quarter have materially effected, or reasonably likely to materially effect our internal control over financial reportingSecurities. Based on the evaluation we conducted, management has concluded that during the fiscal quarter ending June 30, 2010, there were no changes in the Company's internal control over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. The Company's disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and the Principal Executive Officer and the Principal Financial Officer have concluded that these controls and procedures are effective at the "reasonable assurance" level.

~~PART~~None. ~~II – OTHER INFORMATION~~

Item 14. ~~Legal~~Submission ~~Proceedings~~of Matters to a Vote of Security Holders.

~~We are not currently a party to any legal proceedings~~None.

Item 1A5. ~~Risk~~Other ~~Factors~~Information.

~~Not~~On ~~applicable~~February 6, 2011, nine of the claims acquired by the Company from 7167415 lapsed. The Company continually evaluates the potential of its properties for commercially valuable mineralization and will periodically acquire additional claims or let claims lapse. As of the date of this Report, the Company’s limited cash resources are requiring the Company to concentrate its efforts on the properties thought by management to have the greatest commercial value which may mean abandoning claims that may have merit but are of lower perceived value.

Item 26. ~~Unregistered Sales of Equity Securities and Use of Proceeds~~Exhibits.

None.

31.1	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Principal Executive Officer and Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

~~Item~~SIGNATURES ~~3. Defaults Upon Senior Securities.~~

~~None~~In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Item 4. Submission of Matters to a Vote of Security Holders.

		PURE MINERALS INC.
		(Registrant)


Date: March 10, 2011		By: /s/ Nicolas Matossian
		Nicolas Matossian
		President, Principal Executive Officer and
		Principal Financial Officer

The following matters were approved by the shareholders of the Company at a Special Meeting of Shareholders held on June 23, 2010:

	1)	An amendment to the Company’s Articles of Incorporation to effect a reverse stock split of 84 to 1, without changing the authorized capital thereof.
	2)	An amendment to the Company’s Articles of Incorporation to change the name of the Company to “Pure Minerals, Inc.”

Each of these items were approved by a vote of 6,500,000, or approximately 52% in favor, and none opposed with no abstentions. The Articles of Amendment to effect these changes will be filed immediately prior to the closing of the Share Exchange with 7167415.

Item 5. Other Information.

None.

Item 6.	Exhibits.
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		PURE PHARMACEUTICALS CORPORATION
		(Registrant)
Date: August 23, 2010		By: /s/ Roger Gordon
		Roger Gordon
		President, Principal Executive Officer and Director
Date: August 23, 2010		By: /s/ Charlie Lee
		Charlie Lee
		Secretary and Principal Accounting Officer

Filing Compare · Pure Minerals, Inc.